Acetyl-L-Carnitine in Type 2 Diabetes (DIABASI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00984750
Recruitment Status : Completed
First Posted : September 25, 2009
Last Update Posted : February 25, 2013
Leadiant Biosciences, Inc.
Information provided by (Responsible Party):
Mario Negri Institute for Pharmacological Research

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : May 2012
  Study Completion Date : December 2012